Operating Profit változás Dátum
AbbVie USD 3.2B 914M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Alterity Therapeutics Limited AUD -7772080 2.99M 2023-06
Amarin USD -21451000 2.51M 2023-09
Amgen USD 1.27B 819M 2023-12
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Cipla INR 14.44B 1.89B 2023-09
CSL USD 934.7M 1.2B 2023-06
Cytokinetics USD -127418000 5.15M 2023-12
Daiichi Sankyo JPY 51.03B 7B 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Geron USD -54289000 6.68M 2023-12
Grifols EUR 250.59M 7.19M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Heron Therapeutics USD -24929000 17.47M 2023-09
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Merck USD -1933000000 7.68B 2023-12
Minerva Neurosciences USD -6079000 1.56M 2023-09
Moderna USD 6M 2.02B 2023-12
Nektar Therapeutics USD -44864000 5.74M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
United Therapeutics USD 260.1M 66.9M 2023-12
Vanda Pharmaceuticals USD -2867000 4.87M 2023-06



Esperion Therapeutics Üzemi Eredmény - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.